Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Benjamin Switzer, John B.A.G. Haanen, Paul Lorigan, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002835-e002835
Open Access | Times Cited: 16

Showing 16 citing articles:

Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course
Mengjie Jiang, Yujie Hu, Gang Lin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Identification of Comorbidities, Genomic Associations, and Molecular Mechanisms for COVID-19 Using Bioinformatics Approaches
Shudeb Babu Sen Omit, Salma Akhter, Humayan Kabir Rana, et al.
BioMed Research International (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 13
Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature
Filippo Gavi, Paolo Emilio Santoro, Carlotta Amantea, et al.
Microorganisms (2023) Vol. 11, Iss. 1, pp. 176-176
Open Access | Times Cited: 9
The Impact of SARS-CoV-2 Pandemic on Patients with Malignant Melanoma at a Romanian Academic Center: A Four-Year Retrospective Analysis
Hazzaa Aabed, Vlad Bloancă, Zorin Crăiniceanu, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8499-8499
Open Access | Times Cited: 12
In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing
Muhammad Habibulla Alamin, Md. Matiur Rahaman, Farzana Ferdousi, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304425-e0304425
Open Access | Times Cited: 1
Taiwan dermatological association recommendations for coronavirus disease of 2019 vaccination in patients treated with immunotherapeutics
Chih‐Hung Lee, Yu‐Huei Huang, Chia‐Yu Chu
Dermatologica Sinica (2021) Vol. 39, Iss. 4, pp. 169-174
Open Access | Times Cited: 8
The role of circulating biomarkers in predicting the 30-day mortality of immune checkpoint inhibitors-related myocarditis: a retrospective cohort study
Yuansong Zhuang, Quanxu An, Fuhang Wang, et al.
Internal and Emergency Medicine (2023) Vol. 19, Iss. 2, pp. 377-389
Closed Access | Times Cited: 3
Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination
Urška Janžič, Urška Bidovec‐Stojkovič, Katja Mohorčič, et al.
Future Oncology (2022) Vol. 18, Iss. 23, pp. 2537-2550
Open Access | Times Cited: 5
COVID-19 Vaccines and Immunosuppressed Patients With Cancer: Critical Considerations
Naomi Cazeau, Meighan Palazzo, Malvi Savani, et al.
Clinical journal of oncology nursing (2022)
Open Access | Times Cited: 5
Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
Alexander Piening, E C Ebert, Niloufar Khojandi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
SARS-CoV-2 Spike Protein Amplifies the Immunogenicity of Healthy Renal Epithelium in the Presence of Renal Cell Carcinoma
Maryna Somova, Stefan Simm, Jens Ehrhardt, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2038-2038
Open Access
Impact of Covid-19 on the management of patients with metastatic melanoma
Michèle Welti, Phil F. Cheng, Joanna Mangana, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 1370-1379
Open Access | Times Cited: 2
Nivolumab-ipilimumab in renal cell carcinoma metastatic to the bones: A case report.
Marilena Di Napoli, Carmela Pisano, Sergio Venanzio Setola, et al.
PubMed (2022) Vol. 93, Iss. S1, pp. e2022132-e2022132
Closed Access | Times Cited: 1
COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates
Georg Lodde, Melanie Fiedler, Ulf Dittmer, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
COVID-19 pandemic and cancer care: The deadly duo
Ramavath Devendra Naik, Vinod K. Sharma, Annie K Baa
Cancer Research Statistics and Treatment (2022) Vol. 5, Iss. 3, pp. 593-594
Open Access | Times Cited: 1
Adequate Immunogenicity And Low Rate of Severe Adverse Events After SARS-CoV-2 mRNA-Based Vaccination In Patients With Solid Malignancies On Active Treatment Starts To Decline 3 Months After Complete Primary Course of Vaccination
Urška Janžič, Urška Bidovec‐Stojkovič, Katja Mohorčič, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top